Omeros reported $13.92M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 6.82M 516K
Adma Biologics ADMA:US $ 15.89M 1.78M
Aerie Pharmaceuticals AERI:US $ 28.15M 3.38M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Cytokinetics CYTK:US $ 42.72M 9.65M
Dynavax Technologies DVAX:US $ 35.74M 4.27M
Gilead Sciences GILD:US $ 1.36B 274M
Heron Therapeutics HRTX:US $ 32.12M 836K
Insmed INSM:US $ 59.97M 3.23M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Knight Therapeutics Inc GUD:CN C$ 21.49M 2.97M
Macrogenics MGNX:US $ 13.67M 2.58M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Omeros OMER:US $ 13.92M 2.96M
Pacira Pharmaceuticals PCRX:US $ 65M 743K
Pfizer PFE:US $ 3.2B 506M
Regulus Therapeutics RGLS:US $ 2.47M 423K
Sangamo Biosciences SGMO:US $ 15.09M 185K
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
United Therapeutics UTHR:US $ 141.5M 62.5M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
Vital Therapies VTL:US $ 4.07M 82K
Xoma XOMA:US $ 5.71M 594K